Catherine J Field Selected Research

docosahexaenoylascorbic acid (DHA-As)

1/2022	Docosahexaenoic acid enrichment of tumor phospholipid membranes increases tumor necroptosis in mice bearing triple negative breast cancer patient-derived xenografts.
5/2021	Dietary Reference Intakes based on chronic disease endpoints: outcomes from a case study workshop for omega 3's EPA and DHA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine J Field Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 01/2002
14	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2003
13	Obesity 04/2022 - 11/2008
9	Infections 11/2020 - 01/2002
8	Insulin Resistance 04/2022 - 08/2003
7	Inflammation (Inflammations) 01/2020 - 01/2010
5	Body Weight (Weight, Body) 01/2021 - 11/2008
5	Intestinal Failure 09/2018 - 01/2016
4	Atherosclerosis 01/2021 - 03/2014
4	Liver Diseases (Liver Disease) 01/2016 - 08/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012 - 11/2009
3	Hypersensitivity (Allergy) 01/2022 - 10/2008
3	Prader-Willi Syndrome (Syndrome, Prader-Willi) 03/2021 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 02/2021 - 08/2017
3	Malnutrition (Nutritional Deficiencies) 12/2020 - 11/2006
3	Critical Illness (Critically Ill) 02/2015 - 06/2012
3	Dyslipidemias (Dyslipidemia) 08/2012 - 11/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2021
2	Birth Weight (Birth Weights) 01/2022 - 03/2018
2	Triple Negative Breast Neoplasms 01/2022 - 09/2019
2	Fatigue 01/2022 - 10/2021
2	Necrosis 01/2022 - 01/2017
2	Chronic Disease (Chronic Diseases) 05/2021 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2020
2	Weight Gain 01/2020 - 09/2016
2	Colonic Neoplasms (Colon Cancer) 12/2017 - 01/2012
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 08/2009
2	Glucose Intolerance 09/2016 - 01/2012
2	Hyperlipidemias (Hyperlipidemia) 04/2016 - 08/2012
2	Colitis 01/2015 - 12/2007
2	Anorexia 08/2009 - 11/2006
2	Diarrhea 04/2008 - 12/2007
1	Pediatric Obesity 10/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 07/2021

Drug/Important Bio-Agent (IBA)

15	LipidsIBA 01/2022 - 03/2007
13	Docosahexaenoic AcidsIBA 01/2022 - 07/2005
11	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2005
10	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2021 - 05/2002
8	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 01/2002
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
7	Fatty Acids (Saturated Fatty Acids)IBA 04/2021 - 01/2002
6	Hormones (Hormone)IBA 04/2022 - 05/2003
6	Insulin (Novolin)FDA Link 07/2021 - 08/2003
6	Eicosapentaenoic AcidIBA 03/2021 - 07/2005
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2021 - 10/2008
6	Choline (Choline Chloride)IBA 01/2021 - 03/2014
5	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 08/2003
5	CytokinesIBA 01/2022 - 01/2006
5	Vitamin D FDA LinkGeneric 12/2020 - 12/2014
5	Irinotecan (Camptosar)FDA LinkGeneric 12/2017 - 12/2007
5	Fish OilsIBA 12/2017 - 02/2015
5	Conjugated Linoleic AcidsIBA 08/2012 - 01/2002
5	Glutamine (L-Glutamine)FDA Link 09/2011 - 01/2002
4	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 10/2018
4	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021 - 01/2002
4	EmulsionsIBA 09/2018 - 06/2012
4	11-octadecenoic acid (vaccenic acid)IBA 04/2016 - 01/2010
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2017
3	CholesterolIBA 01/2021 - 03/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2017
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2020 - 12/2014
3	LDL Receptors (LDL Receptor)IBA 01/2020 - 03/2014
3	Triglycerides (Triacylglycerol)IBA 01/2016 - 11/2009
3	ThymidineIBA 07/2005 - 01/2002
2	Interleukin-2 (IL2)IBA 01/2022 - 05/2002
2	docosahexaenoylascorbic acid (DHA-As)IBA 01/2022 - 05/2021
2	Docetaxel (Taxotere)FDA Link 01/2022 - 09/2019
2	IronIBA 12/2020 - 01/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2019
2	Arachidonic Acid (Vitamin F)IBA 01/2020 - 01/2002
2	hydroxide ionIBA 03/2019 - 03/2018
2	AntioxidantsIBA 04/2018 - 01/2012
2	Fluorouracil (Carac)FDA LinkGeneric 12/2017 - 08/2009
2	InterleukinsIBA 01/2017 - 01/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 09/2016 - 12/2014
2	Soybean Oil FDA LinkGeneric 01/2016 - 02/2015
2	AntigensIBA 01/2015 - 01/2006
2	AcidsIBA 11/2012 - 01/2004
2	Vitamin E FDA LinkGeneric 01/2012 - 01/2002
2	Insulin-Like Growth Factor I (IGF-1)IBA 05/2009 - 08/2003
2	Linoleic Acid (Linoleate)IBA 05/2009 - 01/2002
2	GlucuronidaseIBA 04/2008 - 12/2007
2	EnzymesIBA 04/2008 - 12/2007
2	phosphatidylethanolamineIBA 05/2002 - 01/2002
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 04/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2002
11	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
5	Parenteral Nutrition 09/2018 - 08/2015
2	Palliative Care (Palliative Therapy) 03/2021 - 11/2006
1	Aftercare (After-Treatment) 10/2021
1	Neoadjuvant Therapy 03/2021
1	High-Protein Diet 03/2021